These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32963492)

  • 1. Overexpression of Ubiquitin-Specific Protease 2 (USP2) in the Heart Suppressed Pressure Overload-Induced Cardiac Remodeling.
    Xing J; Li P; Hong J; Wang M; Liu Y; Gao Y; Dong J; Gu H; Li L
    Mediators Inflamm; 2020; 2020():4121750. PubMed ID: 32963492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.
    Shimano M; Ouchi N; Nakamura K; van Wijk B; Ohashi K; Asaumi Y; Higuchi A; Pimentel DR; Sam F; Murohara T; van den Hoff MJ; Walsh K
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E899-906. PubMed ID: 21987816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis.
    Wang X; Zou Y; Chen Z; Li Y; Pan L; Wang Y; Liu M; Yin C; Wu J; Yang C; Zhang L; Li C; Huang Z; Wang D; Qian J; Ge J; Zou Y; Gong H
    Theranostics; 2021; 11(3):1249-1268. PubMed ID: 33391533
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro.
    Zhang N; An X; Lang P; Wang F; Xie Y
    Biomed Pharmacother; 2019 Jan; 109():1016-1023. PubMed ID: 30551351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D attenuates pressure overload-induced cardiac remodeling and dysfunction in mice.
    Zhang L; Yan X; Zhang YL; Bai J; Hidru TH; Wang QS; Li HH
    J Steroid Biochem Mol Biol; 2018 Apr; 178():293-302. PubMed ID: 29337094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.
    Wang X; Li W; Yue Q; Du W; Li Y; Liu F; Yang L; Xu L; Zhao R; Hu J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
    He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
    Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in ventricular pressure stimulates cardiac repair and remodeling.
    Unno K; Oikonomopoulos A; Fujikawa Y; Okuno Y; Narita S; Kato T; Hayashida R; Kondo K; Shibata R; Murohara T; Yang Y; Dangwal S; Sereti KI; Yiling Q; Johnson K; Jha A; Sosnovik DE; Fann Y; Liao R
    J Mol Cell Cardiol; 2019 Aug; 133():174-187. PubMed ID: 31220468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling.
    Zhang T; Li L; Mo X; Xie S; Liu S; Zhao N; Zhang H; Chen S; Zeng X; Wang S; Deng W; Tang Q
    Phytomedicine; 2024 Dec; 135():156054. PubMed ID: 39306883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.
    Matsuhashi T; Endo J; Katsumata Y; Yamamoto T; Shimizu N; Yoshikawa N; Kataoka M; Isobe S; Moriyama H; Goto S; Fukuda K; Tanaka H; Sano M
    J Mol Cell Cardiol; 2019 May; 130():122-130. PubMed ID: 30946837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling.
    Chen F; Li X; Zhao J; Geng J; Xie J; Xu B
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):567-576. PubMed ID: 32748023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload.
    You J; Li X; Dai F; Liu J; Zhang Q; Guo W
    Clin Exp Hypertens; 2023 Dec; 45(1):2189138. PubMed ID: 36906959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis.
    Fu D; Luo J; Wu Y; Zhang L; Li L; Chen H; Wen T; Fu Y; Xiong W
    Mol Cell Endocrinol; 2023 Jul; 571():111938. PubMed ID: 37100191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgolide A protects adverse cardiac remodeling through enhancing antioxidation and nitric oxide utilization in mice with pressure overload.
    You W; Wu Z; Ye F; Wu X
    Pharmazie; 2019 Nov; 74(11):698-702. PubMed ID: 31739841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.